← Eichor
Study identifier: NCT07693205 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Prospective, Randomized, Subject- and Examiner-Masked, Multicenter Study Comparing Bilateral Clareon TruPlus and Bilateral Clareon Monofocal Intraocular Lens Implantation (Spherical and Toric) in Cataract Subjects

Condition: Cataract  ·  Sponsor: Berkeley Eye Center

PhasePhase 4
Planned participants180
Who can joinAll sexes, 22 Years to no upper limit
Healthy volunteersNo

About this study

This investigator-initiated trial is a prospective, randomized, parallel-group, bilateral implantation study comparing Clareon TruPlus versus Clareon monofocal intraocular lenses (IOLs). Spherical and toric models are permitted in both arms based on standardized preoperative planning and clinical indication. Subjects and postoperative examiners/technicians will be masked to IOL assignment; surgeons will not be masked. The overall structure is modeled after randomized bilateral implantation cataract study designs with a Month 3 primary endpoint visit.

This description comes directly from the study's public registry record.

Talk to the study team

Tetiana Huff  ·  713-620-7640  ·  tetiana.huff@berkeleyeye.com

Always discuss trial participation with your own doctor first.

Locations (1)

Berkeley Eye Center - Sugar LandSugar Land, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07693205